LOS ANGELES--(BUSINESS WIRE)--A securities fraud class action lawsuit has been filed against Tenax Therapeutics, Inc. ("Tenax" or the "Company") (NASDAQ: TENX) on behalf of investors who purchased or otherwise acquired the Company's securities between November 13, 2023 and August 7, 2026, inclusive. Glancy Prongay Wolke & Rotter LLP ("Glancy") today announced the filing. The Tenax Therapeutics, Inc. case, Katz v. Tenax Therapeutics, Inc. et al., was filed on October 26, 2026 in the U.S. Dis. ...